Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
ClinicalTrials.gov study NCT00907036. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called
ClinicalTrials.gov study NCT06385522. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treatment for Subjects With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00117897. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00521261. IPD Sharing: Not stated. Countries: 0. Publications: 0.
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00893477. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
ClinicalTrials.gov study NCT07157579. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04220008. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06190457. IPD Sharing: NO. Countries: 0. Publications: 0.
CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06486337. IPD Sharing: NO. Countries: 0. Publications: 0.
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study
ClinicalTrials.gov study NCT00837174. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma
ClinicalTrials.gov study NCT02808520. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)
ClinicalTrials.gov study NCT00517049. IPD Sharing: Not stated. Countries: 0. Publications: 0.
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00024115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02281279. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00452127. IPD Sharing: Not stated. Countries: 0. Publications: 0.
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00985699. IPD Sharing: Not stated. Countries: 0. Publications: 0.
High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00544570. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00265928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05013372. IPD Sharing: NO. Countries: 0. Publications: 0.
Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma
ClinicalTrials.gov study NCT02715843. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.